In this podcast, Joseph Solomkin, MD, answers our questions about the IGNITE4 trial, which evaluated eravacycline vs meropenem for the treatment of intra-abdominal infections among acutely hospitalized patients. More at: www.consultant360.com/infectious-diseases.

In this podcast, Joseph Solomkin, MD, answers our questions about the IGNITE4 trial, which evaluated eravacycline vs meropenem for the treatment of intra-abdominal infections among acutely hospitalized patients. More at: www.consultant360.com/infectious-diseases.

In this podcast,&nbsp;Joseph Solomkin, MD, answers our questions about the IGNITE4 trial, which evaluated eravacycline vs meropenem for the treatment of intra-abdominal infections among acutely hospitalized patients. More at: www.consultant360.com/infectious-diseases.

Joseph Solomkin, MD, on the Results From the IGNITE4 Trial

Podcasts360, powered by Consultant360, features short interviews with medical professionals about current research, news, and general information for health care providers in 35+ specialties.

Share Joseph Solomkin, MD, on the Results From the IGNITE4 Trial

Sign up to save your podcasts

Joseph Solomkin, MD, on the Results From the IGNITE4 Trial

Joseph Solomkin, MD, on the Results From the IGNITE4 Trial

More shows like Podcasts360

The Curbsiders Internal Medicine Podcast